Blue Note Therapeutics Product BNT 103 Usability and User Engagement

N/ACompletedNCT05032404

Blue Note Therapeutics15 enrolled

Overview

This test aims to explore product development-focused usability and user engagement.

Sponsor is testing an innovative peer-to-peer communication tool during this trial.

Study Type

INTERVENTIONAL

Allocation

Purpose

DEVICE_FEASIBILITY

Masking

NONE

Enrollment

Conditions

Breast Cancer Female

Interventions

BNT103DEVICE

BNT-103™ is a prescription digital therapeutic specifically designed to treat the symptoms of anxiety and depression related to cancer. There are 10 sessions provided over approximately 10 weeks.

Eligibility

Sex: FEMALEMin age: 35 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient can read, write, and speak in English * Patient is between the ages of 35-55 * Diagnosed with Stage I-III breast cancer * In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study * Apple mobile phone or tablet user * Willing to participate in study protocol Exclusion Criteria: * Any participant not meeting inclusion criteria

Locations (1)

Blue Note Therapeutics

San Francisco, California, United States

Outcomes

Primary Outcomes

Mean mHealth App Usability Questionnaire (MAUQ) for Standalone mHealth Apps Used by Patients

Higher scores indicate higher ease of use / easier to use applications

Time frame: Baseline up to Week 7

Secondary Outcomes

Measure of Current Status - Anxiety (MOCS-A)

The MOCS-A is a 13-item self-report measure developed to assess participants' current self-perceived status on: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed, higher scores indicate greater self-perceived proficiency with these skills.

Time frame: Baseline up to Week 7

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.